Climate action is an integral part of our sustainability strategy. To provide a clear and science-based framework for reducing greenhouse gas emissions, Röchling Medical has set near-term climate targets in line with the Science Based Targets initiative (SBTi).
Our targets have been validated and define measurable emission reductions across both our own operations and our value chain by 2030.
The Science Based Targets initiative (SBTi) supports companies and financial institutions in setting greenhouse gas emission reduction targets based on climate science. Its standards, tools and guidance provide a framework for defining how much and how quickly emissions need to be reduced in order to contribute to global climate goals.
For Röchling Medical, this provides a transparent framework for our climate targets and a clear reference for measuring our progress.

By 2030, from a 2024 base year, Röchling Medical commits to:
*The target boundary includes land-related emissions and removals from biogenic feedstocks.
Scope 1 covers direct greenhouse gas emissions from our own operations.
Scope 2 includes indirect emissions associated with the energy we purchase.
Scope 3 covers other indirect emissions generated across our value chain.
By addressing all three scopes, our climate targets extend beyond our own operations and also consider emissions associated with our broader value chain.
The validation of our climate targets marks an important step in our sustainability journey. The focus now is on working toward these targets, tracking our progress and communicating developments transparently through 2030.
The targets form part of Röchling’s sustainability strategy based on the three areas Products, People and Planet. Within Planet, we focus on reducing greenhouse gas emissions and using energy and resources responsibly
For more information about SBTi, please contact our team.
We look forward to hearing from you.

Malin Aldenius
Specialist Sustainability Global

Maurice Welsch
Specialist Sustainability Global